ITGB3 and gastric cancer: Inhibiting the expression of ITGB3 can increase the expression of miR-124-3p and thus inhibit the migration and invasion of gastric cancer, suggesting that miR-124-3p and ITGB3 may also be promising therapeutic targets for gastric cancer [27].